Angelos Spiliopoulos

Angelos Spiliopoulos has a diverse background in the life sciences and healthcare sectors, currently serving as an Associate at Corallia Ventures since July 2024 and as an Independent Consultant for a stroke therapy spinout from the University of Cambridge. Previously, Angelos held positions at Selvedge Venture, Exogene Ltd. as Chief Of Staff, and Multiomic Health as a Project Manager. Early career experience includes a Consultant Internship at SciTechStrategy and a role as a Student Representative at Imperial College London. Angelos's educational credentials include an MPhil in Bioscience Enterprise from the University of Cambridge, an MS in Functional Omics/Applied Genomics from Imperial College London, and a BS in Biochemistry from Kingston University.